{
    "references": [
        {
            "bibentry": "Prince, M, Ali, GC, Guerchet, M, et al. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther 2016; 8: 23. PMID: 27473681",
            "process_entry": "True",
            "doi": "10.1186/s13195-016-0188-8",
            "pmid": "27473681",
            "pmcid": "PMC4967299",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Alzheimer’s Disease International World Alzheimer Report 2015: The global impact of dementia: an analysis of prevalence, incidence, costs and trends. London: Alzheimer’s Disease International (ADI); 2015 Available at: https://www.alz.co.uk/research/world-report-2015.",
            "process_entry": "True",
            "url": "https://www.alz.co.uk/research/world-report-2015.",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Hardy, J. Testing times for the “amyloid cascade hypothesis”. Neurobiol Aging 2002; 23: 1073–74. PMID: 12470803",
            "process_entry": "True",
            "doi": "10.1016/s0197-4580(02)00042-8",
            "pmid": "12470803",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Goedert, M. Tau protein and neurodegeneration. Semin Cell Dev Biol 2004; 15: 45–9. PMID: 15036206",
            "process_entry": "True",
            "doi": "10.1016/j.semcdb.2003.12.015",
            "pmid": "15036206",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Huang, Y, Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 2012; 148: 1204–22. PMID: 22424230",
            "process_entry": "True",
            "doi": "10.1016/j.cell.2012.02.040",
            "pmid": "22424230",
            "pmcid": "PMC3319071",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Zhao, Y, Zhao, B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev 2013; 2013: 316523. PMID: 23983897",
            "process_entry": "True",
            "doi": "10.1155/2013/316523",
            "pmid": "23983897",
            "pmcid": "PMC3745981",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Anand, R, Gill, KD, Mahdi, AA, et al. Therapeutics of Alzheimer’s disease: past, present and future. Neuropharmacology 2014; 76: 27–50. PMID: 23891641",
            "process_entry": "True",
            "doi": "10.1016/j.neuropharm.2013.07.004",
            "pmid": "23891641",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Terry, AV, Buccafusco, JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 2003; 306: 821–27. PMID: 12805474",
            "process_entry": "True",
            "doi": "10.1124/jpet.102.041616",
            "pmid": "12805474",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Ferri, CP, Prince, M, Brayne, C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112–7. PMID: 16360788",
            "process_entry": "True",
            "doi": "10.1016/S0140-6736(05)67889-0",
            "pmid": "16360788",
            "pmcid": "PMC2850264",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Mushtaq, G, Greig, NH, Khan, JA, et al. Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets 2014; 13: 1432–9. PMID: 25345511",
            "process_entry": "True",
            "doi": "10.2174/1871527313666141023141545",
            "pmid": "25345511",
            "pmcid": "PMC5878042",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Kumar, A, Singh, A, Ekavali, E. A review on Alzheimer's disease pathophysiology and its management: an update. Pharmacol Rep 2015; 67: 195–203. PMID: 25712639",
            "process_entry": "True",
            "doi": "10.1016/j.pharep.2014.09.004",
            "pmid": "25712639",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Li, Q, Yang, H, Chen, Y, et al. Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease. Eur J Med Chem 2017; 132: 294–309. PMID: 28371641",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2017.03.062",
            "pmid": "28371641",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Huang, L, Miao, H, Sun, Y, et al. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease. Eur J Med Chem 2014; 87: 429–39. PMID: 25282266",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2014.09.081",
            "pmid": "25282266",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Ellman, GL, Courtney, KD, Andres, V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95. PMID: 13726518",
            "process_entry": "True",
            "doi": "10.1016/0006-2952(61)90145-9",
            "pmid": "13726518",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Torres, JM, Lira, AF, Silva, DR, et al. Structural insights into cholinesterases inhibition by harmane β-carbolinium derivatives: a kinetics-molecular modeling approach. Phytochemistry 2012; 81: 24–30. PMID: 22717507",
            "process_entry": "True",
            "doi": "10.1016/j.phytochem.2012.05.004",
            "pmid": "22717507",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Biasini, M, Bienert, S, Waterhouse, A, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 2014; 42: W252–8. PMID: 24782522",
            "process_entry": "True",
            "doi": "10.1093/nar/gku340",
            "pmid": "24782522",
            "pmcid": "PMC4086089",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Brus, B, Kosak, U, Turk, S, et al. Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor. J Med Chem 2014; 57: 8167–79. PMID: 25226236",
            "process_entry": "True",
            "doi": "10.1021/jm501195e",
            "pmid": "25226236",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Stewart, JJP. Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. J Mol Model 2007; 13: 1173–213. PMID: 17828561",
            "process_entry": "True",
            "doi": "10.1007/s00894-007-0233-4",
            "pmid": "17828561",
            "pmcid": "PMC2039871",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Jones, G, Willett, P, Glen, RC, et al. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997; 267: 727–48. PMID: 9126849",
            "process_entry": "True",
            "doi": "10.1006/jmbi.1996.0897",
            "pmid": "9126849",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Sant’ana, LDO, Sousa, JLM, Salgueiro, FB, et al. Characterization of monofloral honeys with multivariate analysis of their chemical profile and antioxidant activity. J Food Sci 2012; 71: c135–40.",
            "process_entry": "True",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Benzie, IF, Strain, J. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power: the FRAP assay”. Anal Biochem 1996; 239: 70–6. PMID: 8660627",
            "process_entry": "True",
            "doi": "10.1006/abio.1996.0292",
            "pmid": "8660627",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Pereira, TM, Franco, D, Vitorio, F, et al. Coumarin compounds in medicinal chemistry: some important examples from the last years. Curr Top Med Chem 2018; 18: 124–48. PMID: 29595110",
            "process_entry": "True",
            "doi": "10.2174/1568026618666180329115523",
            "pmid": "29595110",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Sonmez, F, Zengin Kurt, B, Gazioglu, I, et al. Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors. J Enzyme Inhib Med Chem 2017; 32: 285–97. PMID: 28097911",
            "process_entry": "True",
            "doi": "10.1080/14756366.2016.1250753",
            "pmid": "28097911",
            "pmcid": "PMC6010140",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Lima, LM, Barreiro, EJ. Bioisosterism: a useful strategy for molecular modification and drug design. Curr Med Chem 2005; 12: 23–49. PMID: 15638729",
            "process_entry": "True",
            "doi": "10.2174/0929867053363540",
            "pmid": "15638729",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Malhotra, S, Tavakkoli, M, Edraki, N, et al. Neuroprotective and antioxidant activities of 4-methylcoumarins: development of structure–activity relationships. Biol Pharm Bull 2016; 39: 1544–8. PMID: 27582333",
            "process_entry": "True",
            "doi": "10.1248/bpb.b16-00005",
            "pmid": "27582333",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Antoine, D, Olivier, M, Vincent, Z. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017; 7: 42717. PMID: 28256516",
            "process_entry": "True",
            "doi": "10.1038/srep42717",
            "pmid": "28256516",
            "pmcid": "PMC5335600",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Antoine, D, Vincent, Z. A boiled‐egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 2016; 11: 1117–21. PMID: 27218427",
            "process_entry": "True",
            "doi": "10.1002/cmdc.201600182",
            "pmid": "27218427",
            "pmcid": "PMC5089604",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Lipinski, CA, Lombardo, F, Dominy, BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001; 46: 3–26. PMID: 11259830",
            "process_entry": "True",
            "doi": "10.1016/s0169-409x(00)00129-0",
            "pmid": "11259830",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Ghose, AK, Viswanadhan, VN, Wendoloski, JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1999; 1: 55–68. PMID: 10746014",
            "process_entry": "True",
            "doi": "10.1021/cc9800071",
            "pmid": "10746014",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Veber, DF, Stephen, RJ, Hung-Yuan, C, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002; 45: 2615–23. PMID: 12036371",
            "process_entry": "True",
            "doi": "10.1021/jm020017n",
            "pmid": "12036371",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Egan, WJ, Merz, KM, Baldwin, JJ. Prediction of drug absorption using multivariate statistics. J Med Chem 2000; 43: 3867–77. PMID: 11052792",
            "process_entry": "True",
            "doi": "10.1021/jm000292e",
            "pmid": "11052792",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Muegge, I, Heald, SL, Brittelli, D. Simple selection criteria for drug-like chemical matter. J Med Chem 2001; 44: 1841–6. PMID: 11384230",
            "process_entry": "True",
            "doi": "10.1021/jm015507e",
            "pmid": "11384230",
            "xmlid": "CIT0032"
        }
    ],
    "localid": "MED-30727776",
    "doi": "10.1080/14756366.2019.1571270",
    "pmid": "10.1080/14756366.2019.1571270",
    "pmcid": "30727776",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30727776/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,176)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),501,77)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),580,69)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),651,123)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),776,225)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1003,167)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 6,
                "xref_id": "CIT0007",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,110)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 7,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),113,295)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),524,133)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,147)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "CIT0011",
                "rp_string": "11",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),280,227)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),509,233)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[2]/sec[5]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[5]/p),147,43)",
                "containers_title": [
                    "Materials and methods",
                    "Cholinesterase inhibition and kinetics assays"
                ]
            }
        ],
        [
            {
                "n_rp": 13,
                "xref_id": "CIT0016",
                "rp_string": "16",
                "rp_xpath": "/article/body/sec[2]/sec[6]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[6]/p),1,354)",
                "containers_title": [
                    "Materials and methods",
                    "Molecular modeling"
                ],
                "pl_string": "For EeAChE (Electrophorus electricus), the PDB structure 1C2O was used; for EqBuChE (Equus caballus), a 3 D homology model was necessarily built from a sequence available in the UniProtKB/Swiss-Prot (entry Q9N1N9) with the automated mode of the protein structure homology-modeling server, Swiss-Model16, using as template the human BuChE (PDB 4TPK)17. Spartan’14 program [Wavefunction, Inc.] was utilized to construct and optimize the inhibitors with the PM6 method18. The program GOLD 5.6 (CCDC Software Ltd., Cambridge, UK) was used to for the docking study with the GoldScore scoring function19.",
                "pl_xpath": "/article/body/sec[2]/sec[6]/p"
            },
            {
                "n_rp": 14,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[2]/sec[6]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[6]/p),1,354)",
                "containers_title": [
                    "Materials and methods",
                    "Molecular modeling"
                ],
                "pl_string": "For EeAChE (Electrophorus electricus), the PDB structure 1C2O was used; for EqBuChE (Equus caballus), a 3 D homology model was necessarily built from a sequence available in the UniProtKB/Swiss-Prot (entry Q9N1N9) with the automated mode of the protein structure homology-modeling server, Swiss-Model16, using as template the human BuChE (PDB 4TPK)17. Spartan’14 program [Wavefunction, Inc.] was utilized to construct and optimize the inhibitors with the PM6 method18. The program GOLD 5.6 (CCDC Software Ltd., Cambridge, UK) was used to for the docking study with the GoldScore scoring function19.",
                "pl_xpath": "/article/body/sec[2]/sec[6]/p"
            }
        ],
        [
            {
                "n_rp": 15,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[2]/sec[6]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[6]/p),357,117)",
                "containers_title": [
                    "Materials and methods",
                    "Molecular modeling"
                ]
            }
        ],
        [
            {
                "n_rp": 16,
                "xref_id": "CIT0019",
                "rp_string": "19",
                "rp_xpath": "/article/body/sec[2]/sec[6]/p/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[6]/p),476,130)",
                "containers_title": [
                    "Materials and methods",
                    "Molecular modeling"
                ]
            }
        ],
        [
            {
                "n_rp": 17,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[2]/sec[7]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[7]/p),220,145)",
                "containers_title": [
                    "Materials and methods",
                    "Evaluation of the antioxidant activity by the ferric reducing ability of plasma (FRAP) method"
                ]
            }
        ],
        [
            {
                "n_rp": 18,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),1,304)",
                "containers_title": [
                    "Results and discussion",
                    "Compounds design and synthesis"
                ],
                "pl_string": "The design of the novel alkylamino-coumarin derivatives (Scheme 1) was based on the structural requirements for mixed-type selective AChE inhibition present in alkylamino-indanone inhibitor recently described13, as well as on the widespread use of coumarins for this pharmacological activity22,23. The coumarin series was based on: 1- the maintenance of the cyclic alkylamino group, which is responsible for the interaction with the cationic catalytic site (CAS) of AChE, exploring different lengths of methylene linkers (2–6); 2-exchange of the indanone nucleus by the coumarin through non-classical isosterism of ring expansion24; 3- use of hydrophobic groups at position 3 of coumarin, targeting interactions with the peripheral anionic site (PAS) of AChE.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            },
            {
                "n_rp": 19,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),1,304)",
                "containers_title": [
                    "Results and discussion",
                    "Compounds design and synthesis"
                ],
                "pl_string": "The design of the novel alkylamino-coumarin derivatives (Scheme 1) was based on the structural requirements for mixed-type selective AChE inhibition present in alkylamino-indanone inhibitor recently described13, as well as on the widespread use of coumarins for this pharmacological activity22,23. The coumarin series was based on: 1- the maintenance of the cyclic alkylamino group, which is responsible for the interaction with the cationic catalytic site (CAS) of AChE, exploring different lengths of methylene linkers (2–6); 2-exchange of the indanone nucleus by the coumarin through non-classical isosterism of ring expansion24; 3- use of hydrophobic groups at position 3 of coumarin, targeting interactions with the peripheral anionic site (PAS) of AChE.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            },
            {
                "n_rp": 20,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),1,304)",
                "containers_title": [
                    "Results and discussion",
                    "Compounds design and synthesis"
                ],
                "pl_string": "The design of the novel alkylamino-coumarin derivatives (Scheme 1) was based on the structural requirements for mixed-type selective AChE inhibition present in alkylamino-indanone inhibitor recently described13, as well as on the widespread use of coumarins for this pharmacological activity22,23. The coumarin series was based on: 1- the maintenance of the cyclic alkylamino group, which is responsible for the interaction with the cationic catalytic site (CAS) of AChE, exploring different lengths of methylene linkers (2–6); 2-exchange of the indanone nucleus by the coumarin through non-classical isosterism of ring expansion24; 3- use of hydrophobic groups at position 3 of coumarin, targeting interactions with the peripheral anionic site (PAS) of AChE.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            }
        ],
        [
            {
                "n_rp": 21,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),307,462)",
                "containers_title": [
                    "Results and discussion",
                    "Compounds design and synthesis"
                ]
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[1]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Cholinesterase inhibitory activity, biological profile, and SAR analyses"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[1]),522,182)",
                "containers_title": [
                    "Results and discussion",
                    "Cholinesterase inhibitory activity, biological profile, and SAR analyses"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[3]/sec[2]/table-wrap/table-wrap-foot/fn/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/table-wrap/table-wrap-foot/fn/p),301,104)",
                "containers_title": [
                    "Results and discussion",
                    "Cholinesterase inhibitory activity, biological profile, and SAR analyses"
                ]
            }
        ],
        [
            {
                "n_rp": 25,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[2]),181,133)",
                "containers_title": [
                    "Results and discussion",
                    "Cholinesterase inhibitory activity, biological profile, and SAR analyses"
                ]
            }
        ],
        [
            {
                "n_rp": 26,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[2]),84,240)",
                "containers_title": [
                    "Results and discussion",
                    "Cell cytotoxicity and in silico ADMET physico-chemical profile analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 27,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[2]),417,272)",
                "containers_title": [
                    "Results and discussion",
                    "Cell cytotoxicity and in silico ADMET physico-chemical profile analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[2]),691,226)",
                "containers_title": [
                    "Results and discussion",
                    "Cell cytotoxicity and in silico ADMET physico-chemical profile analysis"
                ],
                "pl_string": "Finally, in silico evaluations showed a good ADMET profile for coumarin compounds. Parameters as topological polar surface area (TPSA), consensus Log P, Log S, human intestinal absorption (HIA), blood–brain barrier permeation (BBB), and P‐glycoprotein (P-gP) substrate and drug-likeness profile (Supplementary material)26. TPSA values and consensus Log P ranged from 42.68 to 45.92 and 3.35 to 5.01, respectively. The moderate polarity (PSA < 79 Å2) and relative lipophilicic characteristics put our compounds in the yellow compartment of BOILED‐Egg model (Figure 4), having a high probability to access the CNS27, which is fundamental for the distribution of central‐acting molecules. Additionally, the most potent compounds 4a, 5a and 6a were not considered as P-gP substrate and having a good drug-likeness profile with no one violation on the Lipinski28, Ghose29, Veber30, Egan31 and Muegge32 rules.",
                "pl_xpath": "/article/body/sec[3]/sec[3]/p[2]"
            },
            {
                "n_rp": 29,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[2]),691,226)",
                "containers_title": [
                    "Results and discussion",
                    "Cell cytotoxicity and in silico ADMET physico-chemical profile analysis"
                ],
                "pl_string": "Finally, in silico evaluations showed a good ADMET profile for coumarin compounds. Parameters as topological polar surface area (TPSA), consensus Log P, Log S, human intestinal absorption (HIA), blood–brain barrier permeation (BBB), and P‐glycoprotein (P-gP) substrate and drug-likeness profile (Supplementary material)26. TPSA values and consensus Log P ranged from 42.68 to 45.92 and 3.35 to 5.01, respectively. The moderate polarity (PSA < 79 Å2) and relative lipophilicic characteristics put our compounds in the yellow compartment of BOILED‐Egg model (Figure 4), having a high probability to access the CNS27, which is fundamental for the distribution of central‐acting molecules. Additionally, the most potent compounds 4a, 5a and 6a were not considered as P-gP substrate and having a good drug-likeness profile with no one violation on the Lipinski28, Ghose29, Veber30, Egan31 and Muegge32 rules.",
                "pl_xpath": "/article/body/sec[3]/sec[3]/p[2]"
            },
            {
                "n_rp": 30,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[2]),691,226)",
                "containers_title": [
                    "Results and discussion",
                    "Cell cytotoxicity and in silico ADMET physico-chemical profile analysis"
                ],
                "pl_string": "Finally, in silico evaluations showed a good ADMET profile for coumarin compounds. Parameters as topological polar surface area (TPSA), consensus Log P, Log S, human intestinal absorption (HIA), blood–brain barrier permeation (BBB), and P‐glycoprotein (P-gP) substrate and drug-likeness profile (Supplementary material)26. TPSA values and consensus Log P ranged from 42.68 to 45.92 and 3.35 to 5.01, respectively. The moderate polarity (PSA < 79 Å2) and relative lipophilicic characteristics put our compounds in the yellow compartment of BOILED‐Egg model (Figure 4), having a high probability to access the CNS27, which is fundamental for the distribution of central‐acting molecules. Additionally, the most potent compounds 4a, 5a and 6a were not considered as P-gP substrate and having a good drug-likeness profile with no one violation on the Lipinski28, Ghose29, Veber30, Egan31 and Muegge32 rules.",
                "pl_xpath": "/article/body/sec[3]/sec[3]/p[2]"
            },
            {
                "n_rp": 31,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[2]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[2]),691,226)",
                "containers_title": [
                    "Results and discussion",
                    "Cell cytotoxicity and in silico ADMET physico-chemical profile analysis"
                ],
                "pl_string": "Finally, in silico evaluations showed a good ADMET profile for coumarin compounds. Parameters as topological polar surface area (TPSA), consensus Log P, Log S, human intestinal absorption (HIA), blood–brain barrier permeation (BBB), and P‐glycoprotein (P-gP) substrate and drug-likeness profile (Supplementary material)26. TPSA values and consensus Log P ranged from 42.68 to 45.92 and 3.35 to 5.01, respectively. The moderate polarity (PSA < 79 Å2) and relative lipophilicic characteristics put our compounds in the yellow compartment of BOILED‐Egg model (Figure 4), having a high probability to access the CNS27, which is fundamental for the distribution of central‐acting molecules. Additionally, the most potent compounds 4a, 5a and 6a were not considered as P-gP substrate and having a good drug-likeness profile with no one violation on the Lipinski28, Ghose29, Veber30, Egan31 and Muegge32 rules.",
                "pl_xpath": "/article/body/sec[3]/sec[3]/p[2]"
            },
            {
                "n_rp": 32,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[2]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[2]),691,226)",
                "containers_title": [
                    "Results and discussion",
                    "Cell cytotoxicity and in silico ADMET physico-chemical profile analysis"
                ],
                "pl_string": "Finally, in silico evaluations showed a good ADMET profile for coumarin compounds. Parameters as topological polar surface area (TPSA), consensus Log P, Log S, human intestinal absorption (HIA), blood–brain barrier permeation (BBB), and P‐glycoprotein (P-gP) substrate and drug-likeness profile (Supplementary material)26. TPSA values and consensus Log P ranged from 42.68 to 45.92 and 3.35 to 5.01, respectively. The moderate polarity (PSA < 79 Å2) and relative lipophilicic characteristics put our compounds in the yellow compartment of BOILED‐Egg model (Figure 4), having a high probability to access the CNS27, which is fundamental for the distribution of central‐acting molecules. Additionally, the most potent compounds 4a, 5a and 6a were not considered as P-gP substrate and having a good drug-likeness profile with no one violation on the Lipinski28, Ghose29, Veber30, Egan31 and Muegge32 rules.",
                "pl_xpath": "/article/body/sec[3]/sec[3]/p[2]"
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[3]/sec[3]/fig[2]/caption/p/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/fig[2]/caption/p),1,70)",
                "containers_title": [
                    "Results and discussion",
                    "Cell cytotoxicity and in silico ADMET physico-chemical profile analysis"
                ]
            }
        ]
    ]
}